WO2011151492A1 - Envelope for single drug dose - Google Patents
Envelope for single drug dose Download PDFInfo
- Publication number
- WO2011151492A1 WO2011151492A1 PCT/ES2011/070205 ES2011070205W WO2011151492A1 WO 2011151492 A1 WO2011151492 A1 WO 2011151492A1 ES 2011070205 W ES2011070205 W ES 2011070205W WO 2011151492 A1 WO2011151492 A1 WO 2011151492A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inner cavity
- envelope
- fin
- braille
- anterior
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2203/00—Decoration means, markings, information elements, contents indicators
Definitions
- the present invention relates to a single dose overdose for medicaments.
- This invention is applicable in the field of product packaging, and especially in the packaging of medicines.
- the envelopes used for the commercialization of single-dose medications are currently known; generally formed from complex heat-sealable sheets, formed by several layers of suitable materials to provide the envelope with certain characteristics, oriented to the preservation of the properties of the drug until the moment of its use. These layers can give the complex sheet certain specific characteristics, among others: mechanical strength, opacity, impermeability and a heat-sealable character.
- envelopes are supplied, in a variable number of units, inside a box or container that contains a series of information necessary for its commercialization, such as product name, expiration date and active components. In this way the medicine manufacturer only has to label the box, indicating on the envelope the essential information.
- This type of marketing format is used in the pharmaceutical sector to supply powdered medicines; the envelopes being included in a main container from which they are removed as they are needed, and it is not possible to dispense the envelopes individually because said envelope does not have the legally required information, among others, the necessary Braille identification so that the blind can identify the medicine in question.
- These envelopes generally have an anterior and a posterior surface closed laterally by at least one longitudinal weld, defining a tubular configuration that closes at the upper and lower ends delimiting an inner cavity containing the medicament in question.
- tubular configuration is defined by means of the sheet or sheets that make up the anterior and posterior surfaces of the envelope, it is closed by the lower end, introducing the product to be packaged inside, before performing heat sealing and cutting from its upper end.
- the single-dose envelopes are not suitable, since a part of them cannot be opened or torn for the extraction of a coupon printed on its surface since it is necessary to break them, violating the conservation and hygiene conditions of the contained medicine .
- the envelope of the present invention being of the type formed from a flexible sheet and comprising an anterior surface and a posterior surface laterally closed by at least one longitudinal weld, and at the opposite ends by two transverse welds, delimiting a inner cavity containing the medication in question; it presents some constructive peculiarities oriented to define a surface for the incorporation of braille legends or impact printing, without affecting the tightness of the inner cavity and the integrity of the product or medication contained in the envelope.
- the anterior and posterior surfaces of the envelope have, at least one of the ends of the inner cavity, a conforming extension of a flap, separated from the inner cavity by a welding line or zone, and forming a surface for incorporating braille or impact printing legends, without affecting the tightness of the inner cavity.
- the definition of the aforementioned fin outside the area corresponding to the cavity destined to contain the product or medication allows to form a suitable surface to perform any type of printing or marking, even by punching as the case of braille writing, without any risk that pores occur in the area of the envelope that defines the inner cavity and therefore does not affect the preservation of the medicine contained in the inner cavity or the integrity of the product itself.
- the envelope is formed with a preprinted sheet, at least in those areas intended to form the anterior and posterior surfaces of the inner cavity, which allows, in combination with the definition of the fin discussed above, to include in the envelope all the necessary specifications for the individual commercialization of the envelope containing the medicine.
- said flap has at least a smooth surface forming portion for the incorporation of braille or impact printing legends, so that these legends are tactilely readable by blind people.
- the extensions of the anterior and posterior conformant surfaces of the fin can be simply superimposed and laterally attached, or fixed to each other by heat welding, gluing or any other means of attachment; since this does not affect the essence of the invention.
- the envelope has the particularity of comprising in the fin and in an area close to the inner cavity, a pre-cut line for tearing and separating that portion of the fin that incorporates the identification of the medicine, maintaining the integrity of the inner cavity of the envelope.
- the incorporation of the aforementioned pre-cut line allows the portion of the carrier fin to be separated comfortably and safely from the medication information, without risk of affecting the inner cavity containing the medication.
- FIG. 1 shows a front elevation view of an exemplary embodiment of the single dose envelope for medicaments according to the invention, in which the fin defined in the envelope can be observed for incorporating braille or impact printing captions.
- FIG. 2 shows a profile view of the envelope of the previous figure sectioned by a vertical plane and an enlarged detail of the fin formed in this case by two extensions joined by heat-welding in all its extension and presenting a smooth area forming the surface for the incorporation of braille or impact printing legends.
- FIG. 3 shows a front elevational view of an embodiment variant of the envelope of the previous figure, in which the two conforming extensions of the fin are superimposed and joined by heat welding in part of its surface.
- Figure 4 shows a profile view of the envelope of Figure 3 sectioned by a vertical plane.
- FIG. 5 shows a front elevation view of a alternative for the realization of the single dose envelope for medicaments according to the invention, in which the precut line intended to allow the fin to be separated from the rest of the envelope can be observed.
- FIG. 6 shows a profile view of the envelope according to the previous figure sectioned by a longitudinal plane.
- FIG. 7 shows an elevation view of the improved single-dose envelope, once the pre-cut line is torn, and in which it has represented the flap separated from the rest of the envelope.
- the envelope (1) has an anterior surface (1 1) and a posterior surface (12) formed from heat-welded sheet joined and closed at its sides by means of longitudinal welds (13) and at opposite ends by means of transverse welds (14), delimiting between them an inner cavity (15) intended to contain a medicament, represented in this case by capsules (2).
- the anterior and posterior surfaces (1 1, 12) have, at one of the ends of the inner cavity (15), conforming extensions of a fin (16), separated from the inner cavity (15) by a transverse welding line or zone (14), and which forms a surface for the incorporation of legends (3) in braille or impact printing, although in other embodiments they may also comprise ink prints.
- the extensions of the anterior and posterior surfaces (1, 12) of the fin (16) are superimposed and joined by heat welding only by the longitudinal welding lines (13) of the lateral edges and by the transversal welding line or zone (14), which separates it from the inner cavity (15) of the envelope.
- the fin (16) also has a smooth surface (16) that allows the definition and subsequent tactile reading of the legends (3) in braille or impact printing.
- said fin (16) defines a surface suitable for the definition of legends (3) in relief or by impact, without risk of damaging the area corresponding to the inner cavity (15) or Medicines housed inside.
- the envelope (1) is formed with preprinted heat-sealable sheet, which allows the envelope, in addition to the braille or impact printing legends defined in the fin (16), to incorporate at least one of its anterior and posterior surfaces (1 1, 12) the specifications (4) necessary for the individual marketing of the envelope
- FIG. 5 to 7 An alternative embodiment of the envelope (1) is shown in Figures 5 to 7, which comprises a precut line (5) for tearing and separating in a zone close to the inner cavity (15) of the fin (16). of the portion of the fin (16) that incorporates the information related to the medicament, without damaging said inner cavity (15).
- the precut line (5) is located in an intermediate zone of the transverse weld (14) that separates the fin (16) from the inner cavity (15), so that once the precut line (5) is torn and the fin (16) is separated, the inner cavity (15) remains sealed throughout its perimeter, as shown in Figure 7.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Mechanical Engineering (AREA)
- Composite Materials (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Making Paper Articles (AREA)
- Packages (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
DESCRIPCIÓN SOBRE MONODOSIS PARA MEDICAMENTOS. DESCRIPTION OF MONODOSIS FOR MEDICINES.
Objeto de la invención Object of the invention
La presente invención se refiere a un sobre monodosis para medicamentos. The present invention relates to a single dose overdose for medicaments.
Campo de aplicación de la invención. Field of application of the invention.
Esta invención es aplicable en el campo del envasado de productos, y especialmente en el envasado de medicamentos. This invention is applicable in the field of product packaging, and especially in the packaging of medicines.
Antecedentes de la invención. Background of the invention.
Actualmente son conocidos los sobres utilizados para la comercialización de monodosis de medicamentos; conformados generalmente a partir de láminas complejas termosoldables, conformadas por varias capas de materiales adecuados para proporcionarle al sobre unas características determinadas, orientadas a la preservación de las propiedades del medicamento hasta el momento de su utilización. Estas capas pueden proporcionarle a la lámina compleja determinadas características específicas, entre otras: resistencia mecánica, opacidad, impermeabilidad y un carácter termosoldable. The envelopes used for the commercialization of single-dose medications are currently known; generally formed from complex heat-sealable sheets, formed by several layers of suitable materials to provide the envelope with certain characteristics, oriented to the preservation of the properties of the drug until the moment of its use. These layers can give the complex sheet certain specific characteristics, among others: mechanical strength, opacity, impermeability and a heat-sealable character.
Estos sobres se suministran, en un número variable de unidades, en el interior de una caja o envase que contiene una serie de informaciones necesarias para su comercialización, tales como nombre del producto, fecha de caducidad y componentes activos. De este modo el fabricante del medicamento tan solo tiene que etiquetar la caja, indicando en el sobre la información esencial. These envelopes are supplied, in a variable number of units, inside a box or container that contains a series of information necessary for its commercialization, such as product name, expiration date and active components. In this way the medicine manufacturer only has to label the box, indicating on the envelope the essential information.
Este tipo de formato de comercialización es utilizado en el sector farmacéutico para suministrar medicamentos en polvo; encontrándose incluidos los sobres en un envase principal del que se extraen a medida que se necesitan, no siendo posible dispensar los sobres de forma individual por cuanto dicho sobre no dispone de la información legalmente exigida, entre otras la identificación en Braille necesaria para que los invidentes puedan identificar el medicamento en cuestión. This type of marketing format is used in the pharmaceutical sector to supply powdered medicines; the envelopes being included in a main container from which they are removed as they are needed, and it is not possible to dispense the envelopes individually because said envelope does not have the legally required information, among others, the necessary Braille identification so that the blind can identify the medicine in question.
Estos sobres disponen generalmente de una superficie anterior y otra posterior cerradas lateralmente mediante al menos una soldadura longitudinal, definiendo una configuración tubular que se cierra por los extremos superior e inferior delimitando una cavidad interior contenedora del medicamento en cuestión. These envelopes generally have an anterior and a posterior surface closed laterally by at least one longitudinal weld, defining a tubular configuration that closes at the upper and lower ends delimiting an inner cavity containing the medicament in question.
Concretamente, una vez definida la configuración tubular mediante la lámina o láminas que conforman las superficies anterior y posterior del sobre, éste se cierra por el extremo inferior, introduciéndose el producto a envasar en su interior, antes de realizar el cierre por termosellado y el corte de su extremo superior. Specifically, once the tubular configuration is defined by means of the sheet or sheets that make up the anterior and posterior surfaces of the envelope, it is closed by the lower end, introducing the product to be packaged inside, before performing heat sealing and cutting from its upper end.
La comercialización individual de estos sobres requeriría la incorporación en cada sobre de los textos y leyendas en Braille legalmente exigidas. La incorporación de los textos no constituye un problema ya que se pueden conformar los sobres con láminas preimpresas utilizando técnicas conocidas; sin embargo la incorporación en sobre de leyendas en braille es un problema que no se encuentra actualmente resuelto, ya que el punzonado de la lámina, bien previamente o después de conformar el sobre, para incluir las leyendas en Braille conlleva un riesgo inadmisible de que se pueda perforar la lámina o de crear en la misma poros o microporos ya que ello impediría garantizar la estabilidad de la atmósfera en el interior del envase y el mantenimiento del producto farmacéutico en unas condiciones adecuadas para su posterior consumo. The individual commercialization of these envelopes would require the incorporation in each envelope of the legally required texts and Braille legends. The incorporation of texts is not a problem since envelopes can be formed with preprinted sheets using known techniques; However, the incorporation of an envelope of Braille legends is a problem that is not currently solved, since the punching of the sheet, either previously or after forming the envelope, to include the Braille legends carries an inadmissible risk of can perforate the sheet or create pores or micropores in the same as this would prevent guaranteeing the stability of the atmosphere inside the container and the maintenance of the pharmaceutical product in conditions suitable for later consumption.
Esta problemática se complica en mayor medida cuando el producto envasado se trata de uno o dos comprimidos (o cápsulas), ya que al no mantenerse en una posición estable en la cavidad interior, existe el riesgo de que en la operación de marcado en Braille o de impresión de la fecha de caducidad se destrocen los comprimidos o cápsulas a causa del impacto. Además, en la comercialización individualizada de monodosis de medicamentos existe otro problema asociado con el control de su distribución. Así, cuando se adquieren medicamentos subvencionados por la sanidad pública es preciso que el farmacéutico retire del medicamento el cupón identificativo del mismo y lo incorpore en la receta correspondiente con el fin de justificar la expedición del medicamento y recuperar del correspondiente departamento de sanidad el importe subvencionado. This problem is further complicated when the packaged product is one or two tablets (or capsules), since not maintaining a stable position in the inner cavity, there is a risk that in the Braille marking operation or Printing of the expiration date will destroy the tablets or capsules because of the impact. In addition, in the individualized marketing of single dose medications there is another problem associated with the control of their distribution. Thus, when medicines subsidized by public health are acquired, the pharmacist must remove the identification coupon from the medicine and incorporate it in the corresponding prescription in order to justify the issuance of the medicine and recover the subsidized amount from the corresponding health department .
En este caso, los sobres monodosis no son aptos, ya que no se pueden abrir o desgarrar una parte de los mismos para la extracción de un cupón impreso en su superficie ya que es necesario romperlos, violando las condiciones de conservación e higiene del medicamento contenido. In this case, the single-dose envelopes are not suitable, since a part of them cannot be opened or torn for the extraction of a coupon printed on its surface since it is necessary to break them, violating the conservation and hygiene conditions of the contained medicine .
Por tanto el problema técnico que se plantea es el desarrollo de un sobre monodosis para medicamentos que presente unas características adecuadas para permitir la incorporación de impresiones por impacto, leyendas en braille y cualquier otra información necesaria para permitir su comercialización individualizada, todo ello sin poner en riesgo la integridad del producto alojado en su interior y sin definir en el mismo perforaciones o poros que pudieran afectar a la correcta conservación del producto envasado. Además, se debe resolver la cuestión de poder extraer cupones o porciones de control o identificación de dicho sobre, sin que por ello la cavidad de almacenamiento de los medicamentes se vea alterada en su integridad. Therefore, the technical problem that arises is the development of an overdose for medicines that have adequate characteristics to allow the incorporation of impact impressions, braille legends and any other information necessary to allow individualized marketing, all without putting in risk the integrity of the product housed inside and without defining perforations or pores therein that could affect the correct preservation of the packaged product. In addition, the question of being able to extract coupons or portions of control or identification of said envelope must be resolved, without thereby causing the storage cavity of the medication to be altered in its entirety.
Descripción de la invención Description of the invention
El sobre de la presente invención, siendo del tipo de los conformados a partir de una lámina flexible y que comprenden una superficie anterior y una superficie posterior cerradas lateralmente mediante al menos una soldadura longitudinal, y por los extremos opuestos mediante dos soldaduras transversales, delimitando una cavidad interior contenedora del medicamento en cuestión; presenta unas particularidades constructivas orientadas a definir una superficie para la incorporación de leyendas en braille o de impresión por impacto, sin afectar a la estanqueidad de la cavidad interior y a la integridad del producto o medicamento contenido en el sobre. The envelope of the present invention, being of the type formed from a flexible sheet and comprising an anterior surface and a posterior surface laterally closed by at least one longitudinal weld, and at the opposite ends by two transverse welds, delimiting a inner cavity containing the medication in question; it presents some constructive peculiarities oriented to define a surface for the incorporation of braille legends or impact printing, without affecting the tightness of the inner cavity and the integrity of the product or medication contained in the envelope.
De acuerdo con la invención, las superficies anterior y posterior del sobre presentan, en al menos uno de los extremos de la cavidad interior, una prolongación conformante de una aleta, separada de la cavidad interior por una línea o zona de soldadura, y que conforma una superficie para la incorporación de leyendas en braille o de impresión por impacto, sin afectar a la estanqueidad de la cavidad interior. In accordance with the invention, the anterior and posterior surfaces of the envelope have, at least one of the ends of the inner cavity, a conforming extension of a flap, separated from the inner cavity by a welding line or zone, and forming a surface for incorporating braille or impact printing legends, without affecting the tightness of the inner cavity.
La definición de la mencionada aleta fuera de la zona correspondiente a la cavidad destinada a contener el producto o medicamento, permite conformar una superficie adecuada para realizar cualquier tipo de impresión o mareaje, incluso por punzonado como el caso de la escritura braille, sin riesgo alguno de que se produzcan poros en la zona del sobre que define la cavidad interior y sin afectar por tanto la conservación del medicamento contenido en la cavidad interior ni la integridad del propio producto. The definition of the aforementioned fin outside the area corresponding to the cavity destined to contain the product or medication, allows to form a suitable surface to perform any type of printing or marking, even by punching as the case of braille writing, without any risk that pores occur in the area of the envelope that defines the inner cavity and therefore does not affect the preservation of the medicine contained in the inner cavity or the integrity of the product itself.
En una realización de la invención el sobre está conformado con una lámina preimpresa, al menos en aquellas zonas destinadas a conformar las superficies anterior y posterior de la cavidad interior, lo que permite, en combinación con la definición de la aleta comentada anteriormente, incluir en el sobre todas las especificaciones necesarias para la comercialización individual del sobre que contiene el medicamento. In an embodiment of the invention, the envelope is formed with a preprinted sheet, at least in those areas intended to form the anterior and posterior surfaces of the inner cavity, which allows, in combination with the definition of the fin discussed above, to include in the envelope all the necessary specifications for the individual commercialization of the envelope containing the medicine.
En una realización de la invención la mencionada aleta presenta al menos una porción lisa conformante de la superficie para la incorporación de leyendas en braille o de impresión por impacto, de forma que estas leyendas sean legibles de forma táctil por parte de invidentes. Cabe mencionar que las prolongaciones de las superficies anterior y posterior conformante de la aleta pueden estar simplemente superpuestas y adosadas lateralmente, o fijadas entre sí por termolsoldadura, encolado o cualquier otro medio de unión; ya que ello no afecta a la esencia de la invención. En una alternativa de realización, el sobre presenta la particularidad de comprender en la aleta y en una zona próxima a la cavidad interior, una línea de precorte para el desgarro y separación de aquella porción de la aleta que incorpora la identificación del medicamento, manteniendo la integridad de la cavidad interior del sobre. In an embodiment of the invention said flap has at least a smooth surface forming portion for the incorporation of braille or impact printing legends, so that these legends are tactilely readable by blind people. It should be mentioned that the extensions of the anterior and posterior conformant surfaces of the fin can be simply superimposed and laterally attached, or fixed to each other by heat welding, gluing or any other means of attachment; since this does not affect the essence of the invention. In an alternative embodiment, the envelope has the particularity of comprising in the fin and in an area close to the inner cavity, a pre-cut line for tearing and separating that portion of the fin that incorporates the identification of the medicine, maintaining the integrity of the inner cavity of the envelope.
La incorporación de la mencionada línea de precorte permite separar de forma cómoda y segura la porción de la aleta portadora de la información del medicamento, sin riesgo de afectar la cavidad interior que contiene el medicamento. The incorporation of the aforementioned pre-cut line allows the portion of the carrier fin to be separated comfortably and safely from the medication information, without risk of affecting the inner cavity containing the medication.
Descripción de las figuras. Description of the figures.
Para complementar la descripción que se está realizando y con objeto de facilitar la comprensión de las características de la invención, se acompaña a la presente memoria descriptiva un juego de dibujos en los que, con carácter ilustrativo y no limitativo, se ha representado lo siguiente: To complement the description that is being made and in order to facilitate the understanding of the characteristics of the invention, a set of drawings is attached to the present specification in which, for illustrative and non-limiting purposes, the following has been represented:
- La figura 1 muestra una vista en alzado frontal de un ejemplo de realización del sobre monodosis para medicamentos según la invención, en la que se puede observar la aleta definida en el sobre para incorporación de leyendas en braille o de impresión por impacto. - Figure 1 shows a front elevation view of an exemplary embodiment of the single dose envelope for medicaments according to the invention, in which the fin defined in the envelope can be observed for incorporating braille or impact printing captions.
- La figura 2 muestra una vista de perfil del sobre de la figura anterior seccionado por un plano vertical y un detalle ampliado de la aleta conformada en este caso por dos prolongaciones unidas por termosoldado en toda su extensión y que presentan una zona lisa conformante de la superficie para la incorporación de leyendas en braille o de impresión por impacto. - Figure 2 shows a profile view of the envelope of the previous figure sectioned by a vertical plane and an enlarged detail of the fin formed in this case by two extensions joined by heat-welding in all its extension and presenting a smooth area forming the surface for the incorporation of braille or impact printing legends.
- La figura 3 muestra una vista en alzado frontal de una variante de realización del sobre de la figura anterior, en la que las dos prolongaciones conformantes de la aleta se encuentran superpuestas y unidas por termosoldado en parte de su superficie. - Figure 3 shows a front elevational view of an embodiment variant of the envelope of the previous figure, in which the two conforming extensions of the fin are superimposed and joined by heat welding in part of its surface.
- La figura 4 muestra una vista de perfil del sobre de la figura 3 seccionado por un plano vertical. - Figure 4 shows a profile view of the envelope of Figure 3 sectioned by a vertical plane.
- La figura 5 muestra una vista en alzado frontal de una alternativa de realización del sobre monodosis para medicamentos según la invención, en la que se puede observar la línea de precorte destinada a permitir la separación de la aleta del resto del sobre. - Figure 5 shows a front elevation view of a alternative for the realization of the single dose envelope for medicaments according to the invention, in which the precut line intended to allow the fin to be separated from the rest of the envelope can be observed.
- La figura 6 muestra una vista de perfil del sobre según la figura anterior seccionado por un plano longitudinal. - Figure 6 shows a profile view of the envelope according to the previous figure sectioned by a longitudinal plane.
- La figura 7 muestra una vista en alzado del sobre monodosis mejorado, una vez desgarrada la línea de precorte, y en la que ha representado la aleta separada del resto del sobre. - Figure 7 shows an elevation view of the improved single-dose envelope, once the pre-cut line is torn, and in which it has represented the flap separated from the rest of the envelope.
Realización preferente de la invención Preferred Embodiment of the Invention
En los ejemplos de realización mostrados en las figuras adjuntas el sobre (1 ) presenta una superficie anterior (1 1 ) y una superficie posterior (12) conformadas a partir de lámina termosoldable unidas y cerradas por sus laterales mediante unas soldaduras longitudinales (13) y por los extremos opuestos mediante unas soldaduras transversales (14), delimitando entre si una cavidad interior (15) destinada a contener un medicamento, representado en este caso por unas cápsulas (2). In the exemplary embodiments shown in the attached figures, the envelope (1) has an anterior surface (1 1) and a posterior surface (12) formed from heat-welded sheet joined and closed at its sides by means of longitudinal welds (13) and at opposite ends by means of transverse welds (14), delimiting between them an inner cavity (15) intended to contain a medicament, represented in this case by capsules (2).
De acuerdo con la presente invención las superficies anterior y posterior (1 1 , 12) presentan, en uno de los extremos de la cavidad interior (15), unas prolongaciones conformantes de una aleta (16), separada de la cavidad interior (15) por una línea o zona de soldadura transversal (14), y que conforma una superficie para la incorporación de leyendas (3) en braille o de impresión por impacto, aunque en otras realizaciones también pueden comprender impresiones en tinta. In accordance with the present invention, the anterior and posterior surfaces (1 1, 12) have, at one of the ends of the inner cavity (15), conforming extensions of a fin (16), separated from the inner cavity (15) by a transverse welding line or zone (14), and which forms a surface for the incorporation of legends (3) in braille or impact printing, although in other embodiments they may also comprise ink prints.
En el ejemplo mostrado en las figuras 1 y 2, las prolongaciones de las superficies anterior y posterior (1 1 , 12) conformantes de la aleta (16) se encuentran superpuestas y unidas por termosoldadura en toda su extensión, presentando una porción lisa (17), es decir sin el típico perfil aserrado de las líneas de unión por termosoldado, conformando precisamente dicha porción lisa (17) la superficie destinada a la incorporación de leyendas (3) en braille o de impresión por impacto. De este modo se consigue que las leyendas (3) puedan leerse de forma táctil, sin que interfieran en la lectura los relieves típicos de las zonas líneas de termosoldado. In the example shown in Figures 1 and 2, the extensions of the anterior and posterior surfaces (1 1, 12) forming the flap (16) are superimposed and joined by heat welding throughout its entire length, presenting a smooth portion (17 ), that is to say without the typical sawn profile of the welded joint lines, said smooth portion (17) conforming precisely the surface destined to the incorporation of legends (3) in braille or impact printing. In this way the legends are achieved (3) they can be read in tactile form, without interfering in the reading of the reliefs typical of the heat-welded lines areas.
En el ejemplo de realización mostrado en la figura 2 las prolongaciones de las superficies anterior y posterior (1 1 , 12) conformantes de la aleta (16) se encuentran superpuestas y unidas por termosoldadura solamente por las líneas de soldadura longitudinal (13) de los bordes laterales y por la línea o zona de soldadura transversal (14), que la separa de la cavidad interior (15) del sobre. En este caso, la aleta (16) también presenta una superficie lisa (16) que permite la definición y posterior lectura táctil de las leyendas (3) en braille o de impresión por impacto. In the exemplary embodiment shown in Figure 2, the extensions of the anterior and posterior surfaces (1, 12) of the fin (16) are superimposed and joined by heat welding only by the longitudinal welding lines (13) of the lateral edges and by the transversal welding line or zone (14), which separates it from the inner cavity (15) of the envelope. In this case, the fin (16) also has a smooth surface (16) that allows the definition and subsequent tactile reading of the legends (3) in braille or impact printing.
En cualquier caso, y tal como ha mencionado anteriormente la mencionada aleta (16) define una superficie apta para la definición de las leyendas (3) en relieve o por impacto, sin riesgo de dañar la zona correspondiente a la cavidad interior (15) o los medicamentos alojados en su interior. In any case, and as mentioned above, said fin (16) defines a surface suitable for the definition of legends (3) in relief or by impact, without risk of damaging the area corresponding to the inner cavity (15) or Medicines housed inside.
En la realización mostrada el sobre (1 ) está conformado con lámina termosoldable preimpresa, lo que permite que el sobre, además de las leyendas (3) en braille o de impresión por impacto definidas en la aleta (16), incorpore en al menos una de sus superficies anterior y posterior (1 1 , 12) las especificaciones (4) necesarias para la comercialización individual del sobre In the embodiment shown, the envelope (1) is formed with preprinted heat-sealable sheet, which allows the envelope, in addition to the braille or impact printing legends defined in the fin (16), to incorporate at least one of its anterior and posterior surfaces (1 1, 12) the specifications (4) necessary for the individual marketing of the envelope
(1 )-(one )-
En las figuras 5 a 7 se representa una alternativa de realización del sobre (1 ), el cual comprende en una zona próxima a la cavidad interior (15) de la aleta (16) una línea de precorte (5) para el desgarro y separación de la porción de la aleta (16) que incorpora la información relativa al medicamento, sin dañar dicha cavidad interior (15). An alternative embodiment of the envelope (1) is shown in Figures 5 to 7, which comprises a precut line (5) for tearing and separating in a zone close to the inner cavity (15) of the fin (16). of the portion of the fin (16) that incorporates the information related to the medicament, without damaging said inner cavity (15).
En el ejemplo mostrado en las figuras 5 a 7, la línea de precorte (5) se encuentra situada en una zona intermedia de la soldadura transversal (14) que separa la aleta (16) de la cavidad interior (15), de forma que una vez desgarrada la línea de precorte (5) y separada la aleta (16), la cavidad interior (15) se mantiene sellada por todo su perímetro, tal como se muestra en la figura 7. In the example shown in Figures 5 to 7, the precut line (5) is located in an intermediate zone of the transverse weld (14) that separates the fin (16) from the inner cavity (15), so that once the precut line (5) is torn and the fin (16) is separated, the inner cavity (15) remains sealed throughout its perimeter, as shown in Figure 7.
Una vez descrita suficientemente la naturaleza de la invención, así como un ejemplo de realización preferente, se hace constar a los efectos oportunos que los materiales, forma, tamaño y disposición de los elementos descritos podrán ser modificados, siempre y cuando ello no suponga una alteración de las características esenciales de la invención que se reivindican a continuación. Once the nature of the invention has been sufficiently described, as well as a preferred embodiment, it is stated for the appropriate purposes that the materials, shape, size and arrangement of the described elements may be modified, provided that this does not imply an alteration. of the essential features of the invention that are claimed below.
Claims
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2012013866A MX2012013866A (en) | 2010-05-31 | 2011-03-25 | Envelope for single drug dose. |
| BR112012030612A BR112012030612A2 (en) | 2010-05-31 | 2011-03-25 | double dose drug envelope |
| EP20110789298 EP2578199A4 (en) | 2010-05-31 | 2011-03-25 | Envelope for single drug dose |
| US13/700,498 US20130068828A1 (en) | 2010-05-31 | 2011-03-25 | Envelope for single drug dose |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES201030549U ES1072668Y (en) | 2010-05-31 | 2010-05-31 | ABOUT MONODOSIS FOR MEDICINES |
| ESU201030549 | 2010-05-31 | ||
| ESU201130040 | 2011-01-19 | ||
| ES201130040U ES1073777Y (en) | 2011-01-19 | 2011-01-19 | ON IMPROVED MONODOSIS FOR MEDICINES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2011151492A1 true WO2011151492A1 (en) | 2011-12-08 |
Family
ID=45066218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/ES2011/070205 Ceased WO2011151492A1 (en) | 2010-05-31 | 2011-03-25 | Envelope for single drug dose |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20130068828A1 (en) |
| EP (1) | EP2578199A4 (en) |
| BR (1) | BR112012030612A2 (en) |
| MX (1) | MX2012013866A (en) |
| WO (1) | WO2011151492A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107696730B (en) * | 2016-08-08 | 2019-12-20 | 外贸无锡印刷股份有限公司 | Medicine box braille anti-mixing method |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1816542A (en) * | 1928-02-17 | 1931-07-28 | Winthrop Chem Co Inc | Dispensing device for small commodities |
| US2877893A (en) * | 1957-04-16 | 1959-03-17 | Ivers Lee Co | Package with removable indiciabearing sheet |
| US3358824A (en) * | 1965-08-03 | 1967-12-19 | Hoffmann La Roche | Dispensing of pharmaceuticals |
| US3497982A (en) * | 1968-11-22 | 1970-03-03 | Ciba Geigy Corp | Package and method for dispensing of pharmaceutical preparations |
| US3915212A (en) * | 1973-12-10 | 1975-10-28 | Abbott Lab | Flexible medical fluid container having a combined fill and administration port and reinforced hanger |
| US5064071A (en) * | 1990-04-05 | 1991-11-12 | Kerfoot Corporation | Container apparatus |
| US5390796A (en) * | 1992-10-02 | 1995-02-21 | Kerfoot, Jr.; Franklin W. | Envelope apparatus for dispensing medications from drug files |
| US5908208A (en) * | 1994-04-28 | 1999-06-01 | Promex Medical Inc. | Combination sample dispenser and order form device |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2997166A (en) * | 1959-06-16 | 1961-08-22 | Pratt Mfg Corp | Packages for flat articles such as surgical supplies and method of wrapping such articles |
| US3014638A (en) * | 1960-03-14 | 1961-12-26 | Farley Preston | Package construction |
| US3316839A (en) * | 1966-04-20 | 1967-05-02 | Addressograph Multigraph | Ink package and supply system for duplicating machines |
| US3554435A (en) * | 1969-01-16 | 1971-01-12 | Milprint Inc | Pouch with reinforced edge |
| US3873735A (en) * | 1971-05-04 | 1975-03-25 | Nabisco Inc | Food package for heating and venting |
| US4240552A (en) * | 1979-03-12 | 1980-12-23 | C. R. Laurence Co., Inc. | Display package |
| US4709397A (en) * | 1985-12-24 | 1987-11-24 | John H. Harland Company | Tamper-evident envelope with indicia-forming cohesive layers |
| US4972657A (en) * | 1988-01-11 | 1990-11-27 | Rna, Incorporated | Method of packaging medication for controlled dispensing |
| US5210975A (en) * | 1992-01-17 | 1993-05-18 | Beckerman Jerold L | Seed-sprouting kit |
| US5377836A (en) * | 1993-10-04 | 1995-01-03 | United Industrial Trading Corporation | Blister card display package |
| US5887410A (en) * | 1995-03-01 | 1999-03-30 | International Beauty Network, Inc | Method of molding an packaging of a novelty soap |
| US5609253A (en) * | 1995-06-30 | 1997-03-11 | Ssi Photo I.D. | Data card security display packaging |
| US5702559A (en) * | 1995-07-13 | 1997-12-30 | B&H Manufacturing Company, Inc. | Method and apparatus for applying a tactilely distinguishable marking on an article |
| US5791478A (en) * | 1997-12-05 | 1998-08-11 | Multi-Comp, Inc. | Package assembly for dispensing pharmaceutical medications |
| US6758341B1 (en) * | 1997-12-17 | 2004-07-06 | Livingston Seed, Inc. | Seed envelope and method of packaging seed |
| US6951353B2 (en) * | 1999-05-29 | 2005-10-04 | Nancy Kozlowski | Medication record system and dispenser |
| US6199698B1 (en) * | 1999-12-03 | 2001-03-13 | Alusuisse Technology & Management, Ltd. | Pharmaceutical packaging with separation means |
| US6684561B2 (en) * | 2002-05-03 | 2004-02-03 | Demo L.L.C. | Booklet for use in plant germination and transplantation |
| US7726481B2 (en) * | 2002-08-29 | 2010-06-01 | Colbert Packaging Corporation | Display chamber packaging container and method for making |
| US7264582B2 (en) * | 2004-03-11 | 2007-09-04 | 2004Adploy Limited Partnership | Pouch containers having advertising media and methods for their dissemination |
| GB2414461B (en) * | 2004-05-24 | 2007-09-12 | Mark Rupert Tucker | Form-fill-seal process |
| EP1800645A1 (en) * | 2005-12-21 | 2007-06-27 | Körber AG | Package for medicinal products and the like |
| US7506761B2 (en) * | 2006-02-24 | 2009-03-24 | Navajo Manufacturing Company, Inc. | Drug display card |
| US20080107781A1 (en) * | 2006-11-06 | 2008-05-08 | Christopher Carroll | Food container |
| US20100172604A1 (en) * | 2009-01-06 | 2010-07-08 | Printpack Illinois, Inc. | Reclosable Container with Resealable Flexible Cover and Method for Manufacturing the Same |
-
2011
- 2011-03-25 US US13/700,498 patent/US20130068828A1/en not_active Abandoned
- 2011-03-25 BR BR112012030612A patent/BR112012030612A2/en not_active Application Discontinuation
- 2011-03-25 MX MX2012013866A patent/MX2012013866A/en unknown
- 2011-03-25 WO PCT/ES2011/070205 patent/WO2011151492A1/en not_active Ceased
- 2011-03-25 EP EP20110789298 patent/EP2578199A4/en not_active Withdrawn
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1816542A (en) * | 1928-02-17 | 1931-07-28 | Winthrop Chem Co Inc | Dispensing device for small commodities |
| US2877893A (en) * | 1957-04-16 | 1959-03-17 | Ivers Lee Co | Package with removable indiciabearing sheet |
| US3358824A (en) * | 1965-08-03 | 1967-12-19 | Hoffmann La Roche | Dispensing of pharmaceuticals |
| US3497982A (en) * | 1968-11-22 | 1970-03-03 | Ciba Geigy Corp | Package and method for dispensing of pharmaceutical preparations |
| US3915212A (en) * | 1973-12-10 | 1975-10-28 | Abbott Lab | Flexible medical fluid container having a combined fill and administration port and reinforced hanger |
| US5064071A (en) * | 1990-04-05 | 1991-11-12 | Kerfoot Corporation | Container apparatus |
| US5390796A (en) * | 1992-10-02 | 1995-02-21 | Kerfoot, Jr.; Franklin W. | Envelope apparatus for dispensing medications from drug files |
| US5908208A (en) * | 1994-04-28 | 1999-06-01 | Promex Medical Inc. | Combination sample dispenser and order form device |
Also Published As
| Publication number | Publication date |
|---|---|
| US20130068828A1 (en) | 2013-03-21 |
| EP2578199A4 (en) | 2015-04-22 |
| MX2012013866A (en) | 2013-02-07 |
| BR112012030612A2 (en) | 2016-08-16 |
| EP2578199A1 (en) | 2013-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2718326T3 (en) | Packaging device for medications | |
| ES2770301T3 (en) | Blister pack | |
| ES2358648T3 (en) | NEW MEDICINE PACKING. | |
| ES2353673T3 (en) | CHILD-PROOF BLISTER CONTAINER. | |
| US7543709B2 (en) | Sealing sheet for use to close a container-defining sheet | |
| ES2430057T3 (en) | Film container that includes stacked confectionery product pieces | |
| US20070205132A1 (en) | Sealing sheet for use to close a container-defining sheet | |
| KR20120135482A (en) | Administration methods and packagings for oral medications | |
| ES2701247T3 (en) | Sealing label with identification function and container wrapped with said sealing label | |
| ES2364527T3 (en) | DEVICE AND USE TO SAVE AND PROVIDE MEDICINAL OBLEAS. | |
| JP2004524071A (en) | Packaging means using blister packs | |
| ES2398774T3 (en) | Improved disposable bottle for liquid products, especially pharmaceuticals, medications or cosmetics | |
| ES2611677T3 (en) | Procedure for marking a vial, vial so marked | |
| ES2222902T3 (en) | LABELS AND LABELS. | |
| WO2011151492A1 (en) | Envelope for single drug dose | |
| CN112823125B (en) | Ready-to-sell packaging unit containing at least one pharmaceutical product | |
| US10899519B2 (en) | Support for a product packaged in unit doses, and method for the production thereof | |
| ES1072668U (en) | About monodosis for drugs (Machine-translation by Google Translate, not legally binding) | |
| ITBO20100299A1 (en) | ILLUSTRATIVE INSERT FOR MEDICINAL PRODUCTS. | |
| ES2727074T3 (en) | Tape set containing information cards and blisters and method for assembly | |
| ES1073777U (en) | On improved monodosis for medicines (Machine-translation by Google Translate, not legally binding) | |
| RU2782289C2 (en) | Packaging unit containing at least one pharmaceutical product, group including set of such packaging units, and method for manufacture of such a packaging unit | |
| CN105129212A (en) | Single-body multifunctional medical packaging bag and one-piece multifunctional medical packaging bag | |
| ES2706278T3 (en) | Use of a container to store contraceptive pills | |
| JP2007061138A (en) | Medicine envelope |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11789298 Country of ref document: EP Kind code of ref document: A1 |
|
| REEP | Request for entry into the european phase |
Ref document number: 2011789298 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2011789298 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 13700498 Country of ref document: US |
|
| WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/013866 Country of ref document: MX |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012030612 Country of ref document: BR |
|
| ENP | Entry into the national phase |
Ref document number: 112012030612 Country of ref document: BR Kind code of ref document: A2 Effective date: 20121130 |